<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5298974</article-id><article-id pub-id-type="pmcid-ver">PMC5298974.1</article-id><article-id pub-id-type="pmcaid">5298974</article-id><article-id pub-id-type="pmcaiid">5298974</article-id><article-id pub-id-type="pmid">28232837</article-id><article-id pub-id-type="doi">10.3389/fimmu.2017.00125</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Immunogenicity of a Multi-Epitope DNA Vaccine Encoding Epitopes from Cu&#8211;Zn Superoxide Dismutase and Open Reading Frames of <italic toggle="yes">Brucella abortus</italic> in Mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Escalona</surname><given-names initials="E">Emilia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://frontiersin.org/people/u/410576"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>S&#225;ez</surname><given-names initials="D">Darwin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://frontiersin.org/people/u/311038"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>O&#241;ate</surname><given-names initials="A">Angel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://frontiersin.org/people/u/307306"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Laboratory of Molecular Immunology, Department of Microbiology, Faculty of Biological Sciences, Universidad de Concepci&#243;n</institution>, <addr-line>Concepci&#243;n</addr-line>, <country>Chile</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Clarisa B. Palatnik-de-Sousa, Federal University of Rio de Janeiro, Brazil</p></fn><fn fn-type="edited-by"><p>Reviewed by: Daniel Olive, Institut national de la sant&#233; et de la recherche m&#233;dicale, France; Pablo Penaloza, Northwestern University, USA</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Angel O&#241;ate, <email>aonate@udec.cl</email></corresp><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>09</day><month>2</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><issue-id pub-id-type="pmc-issue-id">284458</issue-id><elocation-id>125</elocation-id><history><date date-type="received"><day>14</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2017</year></date></event><event event-type="pmc-live"><date><day>23</day><month>02</month><year>2017</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-22 19:25:16.147"><day>22</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2017 Escalona, S&#225;ez and O&#241;ate.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Escalona, S&#225;ez and O&#241;ate</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-08-00125.pdf"/><abstract><p>Brucellosis is a bacterial zoonotic disease affecting several mammalian species that is transmitted to humans by direct or indirect contact with infected animals or their products. In cattle, brucellosis is almost invariably caused by <italic toggle="yes">Brucella abortus</italic>. Live, attenuated <italic toggle="yes">Brucella</italic> vaccines are commonly used to prevent illness in cattle, but can cause abortions in pregnant animals. It is, therefore, desirable to design an effective and safer vaccine against <italic toggle="yes">Brucella</italic>. We have used specific <italic toggle="yes">Brucella</italic> antigens that induce immunity and protection against <italic toggle="yes">B. abortus</italic>. A novel recombinant multi-epitope DNA vaccine specific for brucellosis was developed. To design the vaccine construct, we employed bioinformatics tools to predict epitopes present in Cu&#8211;Zn superoxide dismutase and in the open reading frames of the genomic island-3 (BAB1_0260, BAB1_0270, BAB1_0273, and BAB1_0278) of <italic toggle="yes">Brucella</italic>. We successfully designed a multi-epitope DNA plasmid vaccine chimera that encodes and expresses 21 epitopes. This DNA vaccine induced a specific humoral and cellular immune response in BALB/c mice. It induced a typical T-helper 1 response, eliciting production of immunoglobulin G2a and IFN-&#947; particularly associated with the Th1 cell subset of CD4<sup>+</sup> T cells. The production of IL-4, an indicator of Th2 activation, was not detected in splenocytes. Therefore, it is reasonable to suggest that the vaccine induced a predominantly Th1 response. The vaccine induced a statistically significant level of protection in BALB/c mice when challenged with <italic toggle="yes">B. abortus</italic> 2308. This is the first use of an <italic toggle="yes">in silico</italic> strategy to a design a multi-epitope DNA vaccine against <italic toggle="yes">B. abortus</italic>.</p></abstract><kwd-group><kwd>brucellosis</kwd><kwd><italic toggle="yes">Brucella abortus</italic></kwd><kwd>multi-epitope DNA vaccine</kwd><kwd>genomic island 3</kwd><kwd>Cu&#8211;Zn SOD</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">Fondo Nacional de Desarrollo Cient&#237;fico y Tecnol&#243;gico<named-content content-type="fundref-id">10.13039/501100002850</named-content></funding-source><award-id rid="cn01">1130093</award-id></award-group></funding-group><counts><fig-count count="6"/><table-count count="2"/><equation-count count="0"/><ref-count count="59"/><page-count count="10"/><word-count count="7226"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Brucellosis, caused by facultative Gram-negative intracellular coccobacilli grouped in the genus <italic toggle="yes">Brucella</italic> (<xref rid="B1" ref-type="bibr">1</xref>), is a zoonotic disease with a high incidence and prevalence worldwide. Brucellosis affects mammals, and it can considerably undermine the health and productivity of domestic livestock. The most frequent clinical symptom in livestock after <italic toggle="yes">Brucella</italic> infection is abortion (<xref rid="B2" ref-type="bibr">2</xref>). In humans, the disease has a wide spectrum of clinical manifestations. They range from simple fever to major complications in which function in the nervous, digestive, genital-urinary, cardiovascular, and muscular systems is compromised, sometimes leading to death (<xref rid="B3" ref-type="bibr">3</xref>). Brucellosis can impose a significant economic burden on animal production (reduction in milk production, abortions, delayed in conception). In cattle, it has been estimated that more than 300,000 animals, out of the 1.4 billion in the world, are infected (<xref rid="B4" ref-type="bibr">4</xref>). Brucellosis is one of the most common zoonotic diseases in humans, with more than 500,000 cases reported annually. However, depending upon the system of controls and the socioeconomic conditions, official reports only account for a fraction of the true incidence of this disease, and different countries have reported from 0.09 to 1603 cases per million inhabitants (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Infection by <italic toggle="yes">Brucella</italic> spp. is usually associated to an acute inflammatory reaction, the principal mechanism against local proliferation of <italic toggle="yes">Brucella</italic> organisms. Infection initially prompts an innate immune response that reduces the number of bacteria (<xref rid="B6" ref-type="bibr">6</xref>). The innate response activates immunity mediated by cells, in which CD4+ and CD8+ T lymphocytes, macrophages (M&#934;), dendritic cells (DCs), and pro-inflammatory cytokines, such as interferon-gamma (IFN-&#947;) and tumor necrosis factor-alpha (TNF-&#945;), participate to confer protection (<xref rid="B7" ref-type="bibr">7</xref>). Although the host raises strong immune response, <italic toggle="yes">Brucella abortus</italic> has the capacity to survive inside M&#934; and DCs, expressing a number of virulence factors that allow it to reach its replicative niche and to avoid immune-mediated destruction (<xref rid="B8" ref-type="bibr">8</xref>). It has been shown that antigen O protects <italic toggle="yes">Brucella</italic> from intracellular death mechanisms, while lipid A is involved in evasion of the innate immune system during the first stages of infection (<xref rid="B9" ref-type="bibr">9</xref>). Some additional virulence factors have been reported to be involved in intracellular replication and immune evasion. These include VirB type IV secretion (<xref rid="B10" ref-type="bibr">10</xref>), BTP1, a seven-helix transmembrane protein that prevents maturation of DCs (<xref rid="B11" ref-type="bibr">11</xref>), a BvrR/BvrS regulatory system of two components (<xref rid="B12" ref-type="bibr">12</xref>), and the RNA chaperone protein Hfq (<xref rid="B13" ref-type="bibr">13</xref>). <italic toggle="yes">B.&#8201;abortus</italic> contains a Cu&#8211;Zn superoxide dismutase (SOD1), an homodimeric metalloenzyme (<xref rid="B14" ref-type="bibr">14</xref>). SOD1 catalyzes the dismutation of the superoxide anion <inline-formula><mml:math id="M1" overflow="scroll"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>&#8722;</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula> to O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub>, detoxifying superoxide radicals generated during the host antimicrobial immune response (<xref rid="B15" ref-type="bibr">15</xref>). It has been observed that a DNA vaccine with the gene sequence for this protein (<italic toggle="yes">sodC</italic>) is highly immunogenic (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>).</p><p>One characteristic of <italic toggle="yes">Brucella</italic> is a limited genetic diversity. This is manifested by the small number of differences responsible for host preferences and by virulence restrictions (<xref rid="B18" ref-type="bibr">18</xref>). The <italic toggle="yes">Brucella</italic> genome incorporates transfer-acquired mobile elements referred to as genomic islands (GIs). Nine GIs have been identified in <italic toggle="yes">Brucella</italic> (<xref rid="B19" ref-type="bibr">19</xref>). GI-3 is present in <italic toggle="yes">B. abortus, Brucella melitenses</italic>, and <italic toggle="yes">Brucella ovis</italic>. This GI contains 25 genes, many of which have unknown function, and several pseudogenes (<xref rid="B20" ref-type="bibr">20</xref>). GI-3 in <italic toggle="yes">B.&#8201;abortus</italic> 2308 includes open reading frame (ORF) BAB1_0260, BAB1_0270, BAB1_0273, BAB1_0278, and BAB1_0278a. Our group has reported that BAB1_0270, described as a zinc-dependent metallopeptidase protein, and BAB1_0278, which has homology with the GcrA superfamily, are involved in <italic toggle="yes">Brucella</italic> virulence. Their deletion affects the capacity of <italic toggle="yes">Brucella</italic> to invade phagocytic cells and to survive within them (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). Furthermore, DNA vaccine encoding BAB1_0270 (<xref rid="B23" ref-type="bibr">23</xref>), BAB1_0278 (<xref rid="B24" ref-type="bibr">24</xref>), and BAB1_0278a, a hypothetical ABC-type transporter (<xref rid="B25" ref-type="bibr">25</xref>), were able to induce an immune response and protection against <italic toggle="yes">B.&#8201;abortus</italic> 2308 infection. Immunization with the recombinant flagellar protein (BAB1_0260) also induced protection (<xref rid="B26" ref-type="bibr">26</xref>). Based on bioinformatics analysis BAB1_0273, a possible DNA-binding protein, is a putative antigen.</p><p>Despite the existence of effective commercial vaccines against brucellosis and a diagnostic test, it has not been possible to eradicate the disease. The main vaccines currently used for cattle are based on live bacteria attenuated to decrease their pathogenicity. Cattle are often vaccinated with <italic toggle="yes">B. abortus</italic> S19 or RB51, which, although providing good protection, may induce abortion if administered to gravid females (<xref rid="B27" ref-type="bibr">27</xref>), and are potentially infectious to humans (<xref rid="B28" ref-type="bibr">28</xref>). Recent advances in genomics, proteomics, recombinant DNA techniques, and vaccinology have made possible the development of safer vaccines, which overcome the drawbacks associated with live-attenuated vaccines. For example, DNA vaccines offer the possibility of inducing both humoral and cellular immune responses, and potentially can prolong the expression of an antigen (<xref rid="B29" ref-type="bibr">29</xref>). The use of epitopes in the design of this type of vaccine is a new alternative in the development of multi-epitope DNA vaccines (<xref rid="B30" ref-type="bibr">30</xref>&#8211;<xref rid="B32" ref-type="bibr">32</xref>). In this strategy, an informed selection of antigenic determinants that correlate with immunogenicity was used.</p><p>In this study, we have predicted antigenic determinants using bioinformatics tools from any ORF codified in GI-3 from <italic toggle="yes">B. abortus</italic> and designed a multi-epitope chimeric DNA vaccine. Humoral, cell-mediated, and protective immunity induced by this multi-epitope DNA vaccine was examined in BALB/c mice.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2-1"><title>Animals</title><p>Seven- to eight-week-old female isogenic BALB/c mice (obtained from the Instituto de Salud P&#250;blica, Santiago, Chile) were randomly allocated to three groups. Mice were kept in conventional animal facilities and received water and food <italic toggle="yes">ad libitum</italic>. All animals were handled in accordance with the regulations of the Bioethics Committee of the Faculty of Biological Sciences, Universidad de Concepci&#243;n regulations. The Bioethics and Safety committee of the Faculty of Biological Sciences of the Universidad de Concepci&#243;n approved this study. All efforts were made to minimize animal suffering.</p></sec><sec id="S2-2"><title>Bacterial Strains</title><p><italic toggle="yes">Escherichia coli</italic> strain BL21 (DE3) pLys (Novagen, Madison, WI, USA) was used as the host strain for expression of recombinant multi-epitope protein and <italic toggle="yes">E. coli</italic> DH5&#945; (Invitrogen, San Diego, CA, USA) was used for obtaining plasmids. Both strains were grown at 37&#176;C in LB broth. The virulent <italic toggle="yes">B. abortus</italic> 2308 and the attenuated strain RB51 were obtained from our culture collection. Bacterial cells were grown under aerobic conditions in Trypticase soy broth (Difco Laboratories, Detriot, MI, USA) for 72&#8201;h at 37&#176;C.</p></sec><sec id="S2-3"><title>Epitope Prediction</title><p>The selected protein sequences (Table <xref ref-type="table" rid="T1">1</xref>) were obtained from the NCBI Database. To find promising epitopes, we used the Immune Epitope Database (<xref rid="B33" ref-type="bibr">33</xref>). This database contains epitope information from 99% of all papers published about immune epitopes (<xref rid="B33" ref-type="bibr">33</xref>). We used the T Cell Epitope Prediction Tools to find peptides binding to MHC class I and class II molecules. Epitope prediction was performed for H2-D<sup>d</sup>, H2-K<sup>d</sup>, H2-L<sup>d</sup> alleles and H2-IE<sup>d</sup>, H2-IA<sup>d</sup> alleles, and MHC-I and MHC-II haplotypes in BALB/c mice. We used a consensus method consisting of a combination of the Stabilized Matrix Method (<xref rid="B34" ref-type="bibr">34</xref>), Artificial Neural Network (<xref rid="B35" ref-type="bibr">35</xref>), and Scoring Matrices derived from Combinatorial Peptide Libraries (<xref rid="B36" ref-type="bibr">36</xref>). We set a threshold &lt;20 of percentile rank and selected all peptides lower than this.</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p><bold><italic toggle="yes">Brucella abortus</italic> proteins used to design the multi-epitope DNA vaccine</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Protein name</th><th valign="top" align="left" rowspan="1" colspan="1">Locus tag</th><th valign="top" align="left" rowspan="1" colspan="1">Position</th><th valign="top" align="left" rowspan="1" colspan="1">Genebank ID</th><th valign="top" align="center" rowspan="1" colspan="1">Length (aa)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Copper/Zinc superoxide dismutase</td><td align="left" valign="top" rowspan="1" colspan="1">BAB2_0535</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AM040265.1">AM040265.1</ext-link>:534069&#8211;534590</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="CAJ12701.1">CAJ12701.1</ext-link></td><td align="center" valign="top" rowspan="1" colspan="1">173</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Flagellar protein FlgJ</td><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0260</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AM040264.1">AM040264.1</ext-link>:263739&#8211;265859</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="CAJ10216.1">CAJ10216.1</ext-link></td><td align="center" valign="top" rowspan="1" colspan="1">706</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zinc-dependent metallopeptidase</td><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0270</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AM040264.1">AM040264.1</ext-link>:270965&#8211;271513</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="CAJ10226.1">CAJ10226.1</ext-link></td><td align="center" valign="top" rowspan="1" colspan="1">182</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypothetical DNA-binding protein</td><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0273</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AM040264.1">AM040264.1</ext-link>:272920&#8211;273165</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="CAJ10229.1">CAJ10229.1</ext-link></td><td align="center" valign="top" rowspan="1" colspan="1">81</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypothetical GcrA protein</td><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0278</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AM040264.1">AM040264.1</ext-link>:275602&#8211;275838</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="CAJ10234.1">CAJ10234.1</ext-link></td><td align="center" valign="top" rowspan="1" colspan="1">78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypothetical ABC-type transporter</td><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0278a</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="AM040264.1">AM040264.1</ext-link>:275322&#8211;275654</td><td align="left" valign="top" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="EEP63779.1">EEP63779.1</ext-link></td><td align="center" valign="top" rowspan="1" colspan="1">110</td></tr></tbody></table></table-wrap></sec><sec id="S2-4"><title>Construction of Recombinant Plasmids</title><p>pVAX1 vector (Thermo Fisher Scientific Inc., MA, USA), designed for use in the development of DNA vaccines, and pQE80L bacterial laclq vector (Qiagen), for expressing N-terminally 6xHis-tagged proteins, were used to induce the expression of recombinant protein. The multi-epitope genes were chemically synthesized by GenScript, Inc. (Piscataway, NJ, USA), with codon optimization for mouse and <italic toggle="yes">E. coli</italic>. The Kozak or Shine-Dalgarno sequence was included in the respective genes. The genes were inserted into pUC57 to generate two expression vectors: pUC57-MEBe (expressing to the recombinant protein) and pUC57-MEBm (used to construct the DNA vaccine). Both constructs were digested with <italic toggle="yes">Bam</italic>HI-<italic toggle="yes">Pst</italic>I and subcloned into <italic toggle="yes">Bam</italic>HI-<italic toggle="yes">Pst</italic>I-digested pVAX1 or <italic toggle="yes">Bam</italic>HI-<italic toggle="yes">Pst</italic>I-digested pQE80L. We obtained pV-MEB (multi-epitope DNA vaccine for <italic toggle="yes">Brucella</italic>) and pQE80L-MEB plasmids and confirmed them by restriction digestion analysis (Figure <xref ref-type="fig" rid="F1">1</xref>). We observed 1140 base pairs (bp) corresponding to MEBm fragment (A) and 1098&#8201;bp corresponding to MEBe fragment (B), respectively.</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Verification of pV-MEB DNA vaccine and pQE80L-MEB plasmids</bold>. <bold>(A)</bold> Restriction analysis of pV-MEB plasmid digested with <italic toggle="yes">Bam</italic>HI and <italic toggle="yes">Pst</italic>I (line 1) <bold>(B)</bold> Restriction analysis of pQE80L-MEB plasmid digested with <italic toggle="yes">Bam</italic>HI and <italic toggle="yes">Pst</italic>I (line 1). LM, DNA size marker (1&#8201;kb DNA ladder).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-08-00125-g001.jpg"/></fig></sec><sec id="S2-5"><title>Immunization</title><p>BALB/c mice were randomly divided into three groups consisting of 10 mice per group. Group 1 was injected with 100&#8201;&#181;g of the pV-MEB vaccine in 100&#8201;&#181;l of phosphate buffer saline (PBS), divided into two injections of 50&#8201;&#181;l, in each posterior tibialis muscle. As negative controls, groups of mice received either 100&#8201;&#181;g pVAX1 in 100&#8201;&#181;l of PBS or 100&#8201;&#181;l of PBS, injected as described above for the experimental group (<xref rid="B23" ref-type="bibr">23</xref>). All groups were immunized three times at 15-day intervals.</p></sec><sec id="S2-6"><title>Purification of Recombinant Multi-Epitope Protein</title><p>To obtain the multi-epitope recombinant protein, <italic toggle="yes">E. coli</italic> BL-21 were chemically transformed with pQE80L-MEBe, and we standardized the protocols to carry out the purification of the rMEB protein. Transformed bacteria were grown in LB broth at 37&#176;C to mid-log phase [optical density at 600&#8201;nm (OD<sub>600</sub>), 0.6&#8211;0.8]. To induce the expression of recombinant protein, bacteria were cultured with 0.5&#8201;mM Isopropyl &#946;-<sc>d</sc>-1-thiogalactopyranoside (IPTG) for 4&#8201;h at 27&#176;C to induce the expression of recombinant protein. Thereafter, the transformed bacterial cells were collected by centrifugation and then disrupted by sonication in Tris&#8211;HCl buffer plus 0.2&#8201;mM of phenylmethylsulfonyl fluoride (PMSF). This preparation was centrifuged at 12,000&#8201;<italic toggle="yes">g</italic> for 20&#8201;min, the soluble fraction was saved and the insoluble fraction was denatured with Denaturing Binding Buffer (0.2&#8201;mM PMSF; 20&#8201;mM Tris&#8211;HCl pH 8; 0.5&#8201;M NaCl; 6&#8201;M Urea; 10&#8201;mM Imidazole). The his-tagged rMEB protein was purified by Ni<sup>2+</sup>-chelated affinity chromatography with HisTrap FF crude columns (GE Healthcare Life Sciences), according to the manufacturer&#8217;s instructions. The elution was performed with 100&#8201;mM of Imidazole. The eluate was concentrated and desalinated using a filter with a molecular weight exclusion of 10&#8201;kDa (Amicon ultra 100&#8201;K, Millipore, MA, USA). Protein concentration was determined by the Pierce&#8482; BCA Protein Assay kit (Thermo Fisher Scientific Inc.). Recombinant multi-epitope proteins were stored at &#8722;20&#176;C for later use as antigens in a indirect enzyme-linked immunosorbent assay (ELISA) and lymphocyte proliferation assays.</p></sec><sec id="S2-7"><title>Humoral Immune Response</title><p>The antibody isotype IgG, IgG1, and immunoglobulin G2a (IgG2a) titers were measured from peripheral blood using an ELISA. Serum was collected 2&#8201;days before each immunization and 15 days after the last immunization. Ninety-six-well polystyrene microtiter plates (Thermo Fisher Scientific Inc., MA, USA) were coated with 1&#8201;&#181;g/ml of rMEB or 10&#8201;&#181;g/ml of crude <italic toggle="yes">Brucella</italic> protein (CBP) (<xref rid="B37" ref-type="bibr">37</xref>), diluted in 0.05&#8201;M carbonate&#8211;bicarbonate buffer (pH 9.6). After overnight incubation at 4&#176;C, the plates were blocked with 0.8% gelatin in Tris-buffered saline for 1&#8201;h at 37&#176;C. Serial twofold dilutions of sera containing primary antibodies from test and control animals were added and incubated for 3&#8201;h at room temperature. Isotype-specific horseradish peroxidase-conjugated anti-mouse IgG (US Biological, Life Sciences) was added at 1:1000 dilution. After 30&#8201;min of incubation at room temperature, 200&#8201;&#181;l of substrate solution (Sigma-Aldrich, Inc.) was added to each well. Results were read using a VictorX3 Multilabel Plate Reader (PerkinElmer, USA) at 450&#8201;nm. All assays were done in triplicate.</p></sec><sec id="S2-8"><title>Culture of Splenocytes and Lymphocyte Proliferation</title><p>Four weeks after the last immunization, mice were euthanized and their spleens removed under aseptic conditions. The splenocytes were cultured, at a concentration of 4&#8201;&#215;&#8201;10<sup>6</sup> viable cells/ml (100&#8201;&#181;l per well), at 37&#176;C under 5% CO<sub>2</sub> in a 96-well flat-bottom plate (Nunc, Denmark), previously sensitized with 2&#8201;&#181;g/ml or 10&#8201;&#181;g/ml of recombinant proteins (rMEB), or 2&#8201;&#181;g/ml or 10&#8201;&#181;g/ml CBP. Splenocytes were cultured in RPMI 1640 medium (Thermo Fisher Scientific, MA, USA) supplemented with 10% heat-inactivated fetal calf serum (GIBCO BRL), penicillin&#8211;streptomycin (50&#8201;UI of penicillin; 50&#8201;&#181;g/ml streptomycin), and amphotericin B (0.25&#8201;&#181;g/ml). After 72&#8201;h, cells were pulsed for 8&#8201;h with 0.4&#8201;&#956;Ci thymidine (50&#8201;&#956;Ci/mmol; Amersham, UK) per well and the radioactivity incorporated in the DNA measured using a scintillation counter. Concanavalin A (ConA) (Sigma Aldrich, MO, USA), at a concentration of 10&#8201;&#181;g/ml was used as proliferative positive control and 10&#8201;&#181;g/ml albumin protein or 10&#8201;&#181;g/ml total <italic toggle="yes">E. coli</italic> protein (CEP) were used as proliferative negative control. Cell proliferation data were expressed as the stimulation index of triplicate cultures from a cell pool from each group. These were obtained by dividing the amount of <sup>3</sup>H-Thymidine incorporated (c.p.m.) in antigen-stimulated cell cultured by the c.p.m. obtained from cells cultured without antigen (<xref rid="B38" ref-type="bibr">38</xref>).</p></sec><sec id="S2-9"><title>Cytokine ELISAs</title><p>The levels of IFN-&#947; and IL-4 secreted were measured by antigen-capture ELISA. Briefly, spleens were aseptically removed from experimental and control mice, disaggregated to single cells, re-suspended in Red Blood Cell buffer (Promega, Madison, WI, USA) to eliminate erythrocytes, and washed three times using incomplete RPMI 1640 (Thermo Fisher Scientific, MA). Cells were adjusted to a concentration of 4&#8201;&#215;&#8201;10<sup>6</sup> viable cells per ml in RPMI 1640 supplemented with 10% fetal calf serum (Thermo Fisher Scientific, MA, USA) and antibiotic/antimycotic solution (100&#8201;UI penicillin, 100&#8201;&#181;g/ml streptomycin, and 0.25&#8201;&#181;g/ml amphotericin B). Spleen cell suspensions were cultured in 24-well plates (Nunc, Denmark) and stimulated with the recombinant multi-epitope <italic toggle="yes">B. abortus</italic> protein (rMEB) at 2 or 10&#8201;&#181;g/ml CBPs or medium alone. They were incubated for 48&#8201;h at 37&#176;C under 5% CO<sub>2</sub> to induce, <italic toggle="yes">in vitro</italic>, the expression of cytokines. After centrifugation at 400&#8201;&#215;&#8201;<italic toggle="yes">g</italic> for 10&#8201;min, supernatants were collected and cytokines quantified by ELISA sandwich using the Mouse IFN-&#947; and IL-4 ELISA kits (eBiosciences, San Diego, CA, USA), following the manufacturer&#8217;s instructions. All assays were performed in triplicate.</p></sec><sec id="S2-10"><title>Protection Experiment</title><p>The protection experiments were performed as previously described (<xref rid="B16" ref-type="bibr">16</xref>). Briefly, 4&#8201;weeks after last vaccination, four mice from each group were challenged by intraperitoneal injection of 10<sup>4</sup> CFU <italic toggle="yes">B. abortus</italic> 2308 per animal. Two weeks later, infected mice were euthanized and their spleens were homogenized in PBS, with the homogenate serially diluted and cultured in Petri dishes containing agar Columbia supplemented with 5% sheep blood (bioM&#233;riex, Santiago, Chile) for 72&#8201;h at 37&#176;C. Bacterial counts were recorded and the number of CFU per spleen calculated. This experiment was repeated twice. When the immunizations were initiated, one reference-vaccinated control group was immunized with 1&#8201;&#215;&#8201;10<sup>8</sup> CFU <italic toggle="yes">B. abortus</italic> RB51 per mouse. Results are reported as units of protection represented by the difference between mean&#8201;&#177;&#8201;SD of log10 CFU/spleen of the PBS control groups with respect to mean&#8201;&#177;&#8201;SD of log10 CFU/spleen values of experimental groups.</p></sec><sec id="S2-11"><title>Statistical Analysis</title><p>The immune response in mice was analyzed using a two-way analysis of variance (ANOVA) and the protective response was analyzed using a one-way ANOVA. Data were analyzed using Prism 5.0 (GraphPad software). Differences were considered significant if <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05.</p></sec></sec><sec id="S3"><title>Results</title><sec id="S3-1"><title>Epitope Prediction</title><p>Using the Immune Epitope Database (IEDB, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.iedb.org">www.iedb.org</uri>), we identified epitopes suitable for constructing a multi-epitope DNA chimeric vaccine against <italic toggle="yes">B. abortus</italic>. The epitopes identified (Table <xref ref-type="table" rid="T1">1</xref>) are specific for MHC class I and MHC class II molecules. However, while all sequences had putative epitopes for MHC class I and class II molecules, the BAB1_0278 ORF only showed epitopes for MHC class I (Table <xref ref-type="table" rid="T2">2</xref>). Peptides were selected based on having a lower percentile rank score. Non-redundant peptides were selected to construct the DNA vaccine. An immunodominant peptide of the Cu, Zn superoxide dismutase protein from <italic toggle="yes">B. abortus</italic>, described previously in the literature (<xref rid="B39" ref-type="bibr">39</xref>), was also included in the vaccine sequence. Finally, 21 epitopes were used to construct the DNA vaccine. To connect the epitopes, we used a GDGDG linker sequence, a rationally designed sequences used to link multi-epitope vaccines (<xref rid="B40" ref-type="bibr">40</xref>). The final design of the multi-epitope vaccine is shown in Figure <xref ref-type="fig" rid="F2">2</xref>A.</p><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p><bold>Epitope prediction by computer modeling</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Allele</th><th valign="top" align="center" rowspan="1" colspan="1">Pi</th><th valign="top" align="center" rowspan="1" colspan="1">Pf</th><th valign="top" align="left" rowspan="1" colspan="1">Peptide</th><th valign="top" align="left" rowspan="1" colspan="1">Peptide selected</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Cu&#8211;Zn SOD</td><td align="center" valign="top" rowspan="1" colspan="1">MHC-I</td><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">60</td><td align="center" valign="top" rowspan="1" colspan="1">68</td><td align="left" valign="top" rowspan="1" colspan="1">TPGYHGFHV</td><td align="left" valign="top" rowspan="1" colspan="1">TPGYHGFHV</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Kd</td><td align="center" valign="top" rowspan="1" colspan="1">92</td><td align="center" valign="top" rowspan="1" colspan="1">102</td><td align="left" valign="top" rowspan="1" colspan="1">HYDPGNTHHHL</td><td align="left" valign="top" rowspan="1" colspan="1">HYDPGNTHHHL</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">MHC-II</td><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">IASTMVLMAFPAFAE</td><td align="left" valign="top" rowspan="1" colspan="1">FIASTMVLMAFPAFAE</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">FIASTMVLMAFPAFA</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">ASTMVLMAFPAFAES</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0260</td><td align="center" valign="top" rowspan="1" colspan="1">MHC-I</td><td align="center" valign="top" rowspan="1" colspan="1">H-2-Kd</td><td align="center" valign="top" rowspan="1" colspan="1">199</td><td align="center" valign="top" rowspan="1" colspan="1">207</td><td align="left" valign="top" rowspan="1" colspan="1">NYARSVGAI</td><td align="left" valign="top" rowspan="1" colspan="1">NYARSVGAI</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Kd</td><td align="center" valign="top" rowspan="1" colspan="1">311</td><td align="center" valign="top" rowspan="1" colspan="1">322</td><td align="left" valign="top" rowspan="1" colspan="1">SYAAPRQGGVNI</td><td align="left" valign="top" rowspan="1" colspan="1">SYAAPRQGGVNI</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">114</td><td align="center" valign="top" rowspan="1" colspan="1">122</td><td align="left" valign="top" rowspan="1" colspan="1">APGNNFFGI</td><td align="left" valign="top" rowspan="1" colspan="1">APGNNFFGI</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">155</td><td align="center" valign="top" rowspan="1" colspan="1">166</td><td align="left" valign="top" rowspan="1" colspan="1">SPQDSVAGYADF</td><td align="left" valign="top" rowspan="1" colspan="1">SPQDSVAGYADF</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">MHC-II</td><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">353</td><td align="center" valign="top" rowspan="1" colspan="1">367</td><td align="left" valign="top" rowspan="1" colspan="1">NDPMRALQAQKLQLE</td><td align="left" valign="top" rowspan="1" colspan="1">NDPMRALQAQKLQLEM</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0270</td><td align="center" valign="top" rowspan="1" colspan="1">MHC-I</td><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">43</td><td align="left" valign="top" rowspan="1" colspan="1">FPVMDFLEL</td><td align="left" valign="top" rowspan="1" colspan="1">FPVMDFLEL</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">128</td><td align="center" valign="top" rowspan="1" colspan="1">138</td><td align="left" valign="top" rowspan="1" colspan="1">EPQANQFAGEL</td><td align="left" valign="top" rowspan="1" colspan="1">EPQANQFAGEL</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">MHC-II</td><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">60</td><td align="left" valign="top" rowspan="1" colspan="1">CQRMGMVDLRIKTQQ</td><td align="left" valign="top" rowspan="1" colspan="1">LCQRMGMVDLRIKTQQ</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="left" valign="top" rowspan="1" colspan="1">59</td><td align="left" valign="top" rowspan="1" colspan="1">LCQRMGMVDLRIKTQ</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">155</td><td align="center" valign="top" rowspan="1" colspan="1">169</td><td align="left" valign="top" rowspan="1" colspan="1">MQRHSVSRGAADIRL</td><td align="left" valign="top" rowspan="1" colspan="1">VMQRHSVSRGAADIRL</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">154</td><td align="left" valign="top" rowspan="1" colspan="1">168</td><td align="left" valign="top" rowspan="1" colspan="1">VMQRHSVSRGAADIR</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">153</td><td align="left" valign="top" rowspan="1" colspan="1">167</td><td align="left" valign="top" rowspan="1" colspan="1">DVMQRHSVSRGAADI</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0273</td><td align="center" valign="top" rowspan="1" colspan="1">MHC-I</td><td align="center" valign="top" rowspan="1" colspan="1">H-2-Kd</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">43</td><td align="left" valign="top" rowspan="1" colspan="1">RYEGGSGVL</td><td align="left" valign="top" rowspan="1" colspan="1">RYEGGSGVL</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Kd</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">60</td><td align="left" valign="top" rowspan="1" colspan="1">QYIEALIAVLTAA</td><td align="left" valign="top" rowspan="1" colspan="1">QYIEALIAVLTAA</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Kd</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="left" valign="top" rowspan="1" colspan="1">56</td><td align="left" valign="top" rowspan="1" colspan="1">QYIEALIAV</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">MHC-II</td><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">ITAEQLRAARALLKM</td><td align="left" valign="top" rowspan="1" colspan="1">ITAEQLRAARALLKM</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">RAARALLKMEQRALA</td><td align="left" valign="top" rowspan="1" colspan="1">RAARALLKMEQRALA</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0278</td><td align="center" valign="top" rowspan="1" colspan="1">MHC-I</td><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">SPLSEALPMF</td><td align="left" valign="top" rowspan="1" colspan="1">SPLSEALPMF</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">SPLSEALPM</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="left" valign="top" rowspan="1" colspan="1">SPHEGFRL</td><td align="left" valign="top" rowspan="1" colspan="1">SPHEGFRLADL</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="left" valign="top" rowspan="1" colspan="1">SPHEGFRLADL</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BAB1_0278a</td><td align="center" valign="top" rowspan="1" colspan="1">MHC-I</td><td align="center" valign="top" rowspan="1" colspan="1">H-2-Ld</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="left" valign="top" rowspan="1" colspan="1">FPANKKNGYAL</td><td align="left" valign="top" rowspan="1" colspan="1">FPANKKNGYAL</td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="left" valign="top" colspan="6" rowspan="1"><hr/></td></tr><tr><td valign="top" align="center" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">MHC-II</td><td align="center" valign="top" rowspan="1" colspan="1">H2-IAd</td><td align="center" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">58</td><td align="left" valign="top" rowspan="1" colspan="1">SAPASIQEADDFLLA</td><td align="left" valign="top" rowspan="1" colspan="1">SAPASIQEADDFLLA</td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><bold>Pi</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>Pf</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Peptide</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Reference</bold></td></tr><tr><td align="left" valign="top" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cu&#8211;Zn SOD</td><td align="center" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">86</td><td align="left" valign="top" rowspan="1" colspan="1">GGAPGEKDGKIVPAG</td><td align="left" valign="top" rowspan="1" colspan="1">Tabatabai and Pugh (<xref rid="B39" ref-type="bibr">39</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">Pi, initial position of peptides in each protein; Pf, final position of peptides in each protein</italic>.</p></table-wrap-foot></table-wrap><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold>MEB DNA vaccine design and identification of rMEB protein</bold>. <bold>(A)</bold> Multi-epitope vaccine sequence spaced by GDGDG linker sequence. <bold>(B)</bold> SDS-PAGE analysis of rMEB. Lane 1, marker; lane 2, total proteins obtained from insoluble extract from <italic toggle="yes">Escherichia coli</italic> transformed with pQE80L-MEBe plasmid; lane 3, eluent from Ni<sup>2+</sup>-chelated affinity chromatography of the insoluble extract from <italic toggle="yes">E. coli</italic>; lane 4, total proteins obtained from the soluble extract from <italic toggle="yes">E. coli</italic> transformed with pQE80L-MEBe plasmid; lane 5, eluent from Ni<sup>2+</sup>-chelated affinity chromatography of the soluble extract from <italic toggle="yes">E. coli</italic>. <bold>(C)</bold> Western blot analysis of rMEB with anti-His-tag monoclonal antibody.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-08-00125-g002.jpg"/></fig></sec><sec id="S3-2"><title>Production of Recombinant Multi-Epitope Protein of <italic toggle="yes">Brucella</italic></title><p>To construct the recombinant protein, <italic toggle="yes">E. coli</italic> BL21 (DE3) cells were transformed with the pQE80L-MEB plasmid and expression of the 6xHis-Tagged protein was induced. The recombinant protein was mainly expressed in the soluble fraction of the transformed bacteria after their sonication (Figure <xref ref-type="fig" rid="F2">2</xref>B, lane 4). The recombinant protein of <italic toggle="yes">B. abortus</italic> (rMEB) was induced and detected by Western blot. Its weight was ~37&#8201;kDa, the expected mass (Figure <xref ref-type="fig" rid="F2">2</xref>C).</p></sec><sec id="S3-3"><title>Humoral Immune Response of Immunized Mice</title><p>Specific antibodies for rMEB and CBPs were measured in order to evaluate the humoral immune response. We performed ELISAs to detect specific IgG, IgG1, and IgG2a antibodies induced in mice against rMEB and CBP. Serum from mice immunized with multi-epitope DNA vaccine for <italic toggle="yes">Brucella</italic> (pV-MEB) contained significant titers of IgG specific for rMEB at 30&#8201;days after the first immunization. IgG titers were higher at 45&#8201;days, compared to the negative-control groups pVAX and PBS (Figure <xref ref-type="fig" rid="F3">3</xref>A). The same pattern was observed for IgG against CBPs (Figure <xref ref-type="fig" rid="F3">3</xref>B). No rMEB- or CBP-specific IgG1 was detected in serum from mice immunized with pV-MEB (Figures <xref ref-type="fig" rid="F3">3</xref>C,D). Titers of IgG2a antibodies specific for rMEB proteins significantly differed between the pV-MEB groups immunized (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05) only after the second immunization between pV-MEB groups immunized, compared to PBS and pVAX controls (Figure <xref ref-type="fig" rid="F3">3</xref>E). On the other hand, a significant titer of IgG2a specific for CBP was observed after the third immunization with pV-MEB, compared to PBS and pVAX negative controls (Figure <xref ref-type="fig" rid="F3">3</xref>F).</p><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p><bold>Titers of specific IgG (A,B), IgG1 (C,D), and immunoglobulin G2a (E,F) production after immunization with recombinant pV-MEB vaccine</bold>. Sera obtained from each group of mice were used for detection of antibodies against purified rMEB proteins <bold>(A,C,D)</bold> and crude <italic toggle="yes">Brucella</italic> proteins <bold>(B,D,F)</bold> by indirect enzyme-linked immunosorbent assay. Sera obtained at days 0, 15, 30, and 45 post-immunization were serially diluted in phosphate buffer saline and used in the assay (*<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01, and ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-08-00125-g003.jpg"/></fig></sec><sec id="S3-4"><title>Cellular Immune Response</title><p>To evaluate the cellular immune response, splenocytes were obtained from mice immunized with pV-MEB, p-VAX, or PBS at 30&#8201;days after the last immunization. <italic toggle="yes">In vitro</italic> stimulation using splenocytes from pV-MEB mice immunized with 10 or 2&#8201;&#181;g/ml rMEB protein resulted in a significant increase in cell proliferation in relation to the control group (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001 and <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, respectively; Figure <xref ref-type="fig" rid="F4">4</xref>A). <italic toggle="yes">In vitro</italic> stimulation using splenocytes from pV-MEB mice immunized with 10 and 2&#8201;&#181;g/ml of CBP also induced a significant increase in splenocytes proliferation (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001 and <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01, respectively; Figure <xref ref-type="fig" rid="F4">4</xref>B). In this assay, 10&#8201;&#181;g/ml of ConA was used as lymphoproliferation control. It induced a strong lymphoproliferative response in all experimental groups (data not shown). <italic toggle="yes">In vitro</italic> stimulation of splenocytes with 10&#8201;&#181;g/ml crude <italic toggle="yes">E. coli</italic> protein and 10&#8201;&#181;g/ml albumin did not induce proliferation across the different experimental groups (Figure <xref ref-type="fig" rid="F4">4</xref>C).</p><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p><bold>Lymphocyte proliferation assay after <italic toggle="yes">in vitro</italic> stimulation with (A) 10 or 2&#8201;&#181;g/ml recombinant protein, (B) 10 or 2&#8201;&#181;g/ml <italic toggle="yes">Brucella abortus</italic> total proteins (CBP), and (C) 10&#8201;&#181;g/ml of crude <italic toggle="yes">Escherichia coli</italic> proteins and 10&#8201;&#181;g/ml of albumin as control</bold>. Results are shown as mean&#8201;&#177;&#8201;SD of the stimulation index of <sup>3</sup>H-thymidine, incorporated from mouse splenocytes (<italic toggle="yes">n</italic>&#8201;=&#8201;5) (*<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01, and ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-08-00125-g004.jpg"/></fig><p>IFN-&#947; levels in supernatants from cultures of splenocytes obtained from the pV-MEB immunization group re-stimulated with rMEB or CBP were significantly higher than those in the negative-control groups (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001, respectively) (Figure <xref ref-type="fig" rid="F5">5</xref>A). There were no significant difference in levels of IL-4 secretion between the experimental and control groups (Figure <xref ref-type="fig" rid="F5">5</xref>B).</p><fig id="F5" position="float" orientation="portrait"><label>Figure 5</label><caption><p><bold>Determination of IFN-&#947; (A) or IL-4 (B) production</bold>. Splenocytes from pV-MEB pVAX or phosphate buffer saline (PBS) groups were obtained 30&#8201;days after the last immunization, and were re-stimulated <italic toggle="yes">in vitro</italic> with 2&#8201;&#181;g/ml of recombinant MEB proteins or 10&#8201;&#181;g/ml of crude <italic toggle="yes">Brucella</italic> proteins. Each bar represents the geometric mean&#8201;&#177;&#8201;SD (error bars) of the response in spleen cells from individual mice. ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001, statistically significant difference compared to the PBS group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-08-00125-g005.jpg"/></fig></sec><sec id="S3-5"><title>Protection against Virulent <italic toggle="yes">B. abortus</italic> Challenged</title><p>The protective capacity provided by the pV-MEB DNA vaccine was evaluated 6&#8201;weeks after the last immunization. Immunized mice were challenged with 10<sup>4</sup> CFU <italic toggle="yes">B. abortus</italic> 2308, and after 2&#8201;weeks their spleens were removed, homogenized, and cultured. The results showed that pV-MEB DNA vaccine confers protection against <italic toggle="yes">B. abortus</italic> 2308. The DNA vaccine induced 1.14 log<sub>10</sub> units of protection (<italic toggle="yes">P</italic>&#8201;&gt;&#8201;0.005; Figure <xref ref-type="fig" rid="F6">6</xref>) compared to the PBS control group. By comparison, vaccination with live <italic toggle="yes">B. abortus</italic> strain RB51 induced 2.85-log units of protection.</p><fig id="F6" position="float" orientation="portrait"><label>Figure 6</label><caption><p><bold>Protection conferred to BALB/c mice immunized with pV-MEB vaccine against <italic toggle="yes">Brucella abortus</italic> 2308</bold>. Results are shown as mean&#8201;&#177;&#8201;SD of the log<sub>10</sub> CFU of <italic toggle="yes">B. abortus</italic> 2308 per spleen (<italic toggle="yes">n</italic>&#8201;=&#8201;4), **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.01 and ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001. <sup>a</sup>Units of protection represent the difference between log<sub>10</sub> CFU values of the phosphate buffer saline group and the log<sub>10</sub> CFU values of the immunized group.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-08-00125-g006.jpg"/></fig></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>Brucellosis is a worldwide zoonotic disease of increasing incidence. Vaccination of livestock is considered the best prevention method, but it is necessary to generate safer and more effective vaccine formulations (<xref rid="B41" ref-type="bibr">41</xref>). The availability of bioinformatics tools and databases allow the design of vaccines without the need for <italic toggle="yes">in vitro</italic> manipulation of a pathogenic microorganism. Using &#8220;<italic toggle="yes">reverse vaccinology</italic>&#8221; approach, <italic toggle="yes">in silico</italic> genomic databases are screened to identify antigenic sequences for new vaccines (<xref rid="B42" ref-type="bibr">42</xref>). This allows the identification of antigens that would be difficult using traditional methods (<xref rid="B42" ref-type="bibr">42</xref>). It has been observed that recombinant protein vaccines induce a humoral/Th2 immune response and it is suggested that a boost with a protein improve the protective efficacy of the antibodies (<xref rid="B43" ref-type="bibr">43</xref>). The effect of DNA vaccines, however, is based toward a Th1 response (<xref rid="B44" ref-type="bibr">44</xref>&#8211;<xref rid="B46" ref-type="bibr">46</xref>).</p><p>DNA vaccine have a number of advantages, including ease storage, flexibility of antigen codification, and the presence of CpG motifs, which improve the immune response (<xref rid="B45" ref-type="bibr">45</xref>). Mono-antigenic DNA vaccines induce a good immune response, but tend to induce less protection against pathogens compared to poly-antigenic vaccine (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). In the case of <italic toggle="yes">B. abortus</italic>, the three antigens: BCSP31, Cu&#8211;Zn SOD, and L7/L12 ribosomal proteins, when giving together as part of a formulation, improve the immune response against pathogenic <italic toggle="yes">B. abortus</italic> (<xref rid="B49" ref-type="bibr">49</xref>).</p><p>Within the last few years, the use of epitopes in vaccines has become a valid alternative for improving the efficacy of traditional vaccine, based on a &#8220;natural&#8221; form of the pathogen (<xref rid="B50" ref-type="bibr">50</xref>). Multi-epitope peptide DNA vaccines are effective against some viruses (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>) and they are potentially effective against some bacteria such as <italic toggle="yes">Helicobacter pylori</italic> (<xref rid="B53" ref-type="bibr">53</xref>) and in cancer prevention (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>).</p><p>Multi-epitope DNA vaccines more faithfully mimic antigen processing and presentation during natural infection (<xref rid="B30" ref-type="bibr">30</xref>). In addition, multi-epitope DNA vaccines induce more potent immunoreaction than whole protein vaccine (<xref rid="B30" ref-type="bibr">30</xref>). Since the epitopes are derived from multiple antigens and packaged into a relatively small delivery vehicle, the vaccine can induce powerful cross-reactive responses toward multiple antigens and elicit a strong humoral and cellular immune response (<xref rid="B56" ref-type="bibr">56</xref>). In this study, we used bioinformatics methods to identify epitopes on antigenic proteins of <italic toggle="yes">B. abortus</italic> and to design a multi-epitope chimeric DNA vaccine. We performed the epitope prediction using bioinformatics resources available online, including NetChop, SYFPEITHI, or BIMAS. However, these database had a 50% prediction assertiveness about the prediction (<xref rid="B57" ref-type="bibr">57</xref>). The predictive power of the IEDB has been expanded with the provision of a large number of published epitopes and full-scale MHC-binding peptides (<xref rid="B58" ref-type="bibr">58</xref>), so we opted to use the IEDB server. In order to design a rational vaccine against <italic toggle="yes">Brucella</italic>, we focused on finding MHC class I or MHC class II binding peptides known to orchestrate primarily a T-cell immune response, since <italic toggle="yes">B. abortus</italic> is known as a facultative intracellular pathogen (<xref rid="B59" ref-type="bibr">59</xref>). We selected 21 dominant epitopes from ORFs present within GI-3 and proteins described as antigens of immunological interest (Table <xref ref-type="table" rid="T1">1</xref>). Peptides were selected based on their low percentile score using observed redundant sequences as a further selection criterion, choosing peptides with non-redundant sequences (Table <xref ref-type="table" rid="T2">2</xref>). For the theoretical binding of peptides we used the &#8220;GDGDG&#8221; sequence as spacer (Figure <xref ref-type="fig" rid="F2">2</xref>A) (<xref rid="B40" ref-type="bibr">40</xref>). The introduction of GDGDG spacers does not preclude the possibility that such linear arrangements of epitopes might contain other cryptic epitopes. The presence of this spacer at 15&#8211;20 residue intervals might help create some secondary and possibly tertiary structure, thereby facilitating antigen expression&#8201;(<xref rid="B40" ref-type="bibr">40</xref>). Then, we constructed the <italic toggle="yes">B. abortus</italic> multi-epitope chimeric DNA vaccine using of chemical gene synthesis (pV-MEB).</p><p>We, next, proceeded to evaluate the immunogenicity and protective efficacy conferred by immunization with the multi-epitope vaccine, peptides present in Cu&#8211;Zn superoxide dismutase and the ORFs present within GI-3 (BAB1_0260, BAB1_0270, BAB1_0273, and BAB1_0278) of <italic toggle="yes">B. abortus</italic> (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B21" ref-type="bibr">21</xref>&#8211;<xref rid="B26" ref-type="bibr">26</xref>). The results showed that immunization with pV-MEB triggers a MEB-specific humoral and cellular immune response in BALB/c mice. At systemic level pV-MEB promotes the stimulation of MEB-specific IgG2, indicating an adequate induction of a Th1 response. <italic toggle="yes">In vitro</italic> stimulation of splenocytes from pV-MEB immunized mice induced the highest proliferation in response to antigen, confirming the <italic toggle="yes">in vivo</italic> translation of the <italic toggle="yes">MEB</italic> synthetic gene and subsequent induction of a cell-mediated immune response. We used albumin and <italic toggle="yes">E. coli</italic> proteins as control of proliferation and in both cases splenocytes did not proliferate. Therefore, the immune response inducing by pV-MEB DNA vaccine was specific to MEB protein and <italic toggle="yes">Brucella</italic> antigens. Antigen-stimulated splenocytes from vaccinated mice produced IFN-&#947;. The level of IFN-&#947; and the <italic toggle="yes">in vitro</italic> proliferation of splenocytes stimulated by MEB recombinant protein demonstrated that pV-MEB DNA vaccine induces a strong immunoreaction and a polarized Th1 response against <italic toggle="yes">Brucella</italic> infection, which is associated to effective clearance of intracellular pathogens, so essential feature for a <italic toggle="yes">Brucella</italic> vaccine (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B59" ref-type="bibr">59</xref>). The immunogenicity induced by pV-MEB DNA recombinant plasmid was evaluated by challenging immunized mice with <italic toggle="yes">B. abortus</italic> 2308 strain. Our results confirmed that immunization with pV-MEB induced immunogenicity associated with significant protection, but protection induced by attenuated <italic toggle="yes">B. abortus</italic> RB51 was more robust.</p><p>In conclusion, we have shown that a <italic toggle="yes">B. abortus</italic> multi-epitope chimeric DNA vaccine (pV-MEB) elicits strong humoral and cellular protective immunity. Future studies must include an array of epitopes or combination of peptides and adjuvants as alternatives to conventional vaccine design. This study provides a starting point for the development of multi-epitope DNA vaccines against <italic toggle="yes">B. abortus</italic>.</p></sec><sec id="S5"><title>Author Contributions</title><p>EE: construction of recombinant plasmid, analysis <italic toggle="yes">in silico</italic> of determination of epitopes, evaluation of immune response, evaluation of antibodies specificity by ELISA, and writing and discussion of the results. DS: immunization trail, lymphocyte proliferation assays, and protection experiment. AO: programming and monitoring the experiments, performing the analysis, and discussion and writing the manuscript. AO is principal investigator at the FONDECYT grant that funded this work.</p></sec><sec id="S6"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>This work was supported by Grant 1130093 from the Fondo Nacional de Desarrollo Cient&#237;fico y Tecnol&#243;gico (FONDECYT), Santiago, Chile. The authors wish to thank Professor Nelson Fern&#225;ndez (University of Essex, UK) for critical reading and editing of the manuscript.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Percin</surname><given-names>D</given-names></name></person-group><article-title>Microbiology of <italic toggle="yes">Brucella</italic></article-title>. <source>Recent Pat Antiinfect Drug Discov</source> (<year>2012</year>) <volume>8</volume>:<fpage>13</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.2174/1574891X11308010004</pub-id><pub-id pub-id-type="pmid">22812617</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seleem</surname><given-names>M</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>S</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name></person-group>. <article-title>Brucellosis: a re-emerging zoonosis</article-title>. <source>Vet Microbiol</source> (<year>2010</year>) <volume>140</volume>:<fpage>392</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetmic.2009.06.021</pub-id><pub-id pub-id-type="pmid">19604656</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atluri</surname><given-names>V</given-names></name><name name-style="western"><surname>Xavier</surname><given-names>M</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>M</given-names></name><name name-style="western"><surname>den Hartigh</surname><given-names>A</given-names></name><name name-style="western"><surname>Tsolis</surname><given-names>RM</given-names></name></person-group>. <article-title>Interactions of the human pathogenic <italic toggle="yes">Brucella</italic> species with their hosts</article-title>. <source>Annu Rev Microbiol</source> (<year>2011</year>) <volume>65</volume>:<fpage>523</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-micro-090110-102905</pub-id><pub-id pub-id-type="pmid">21939378</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Figueiredo</surname><given-names>P</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>T</given-names></name><name name-style="western"><surname>Rice-Ficht</surname><given-names>A</given-names></name><name name-style="western"><surname>Rossetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Adams</surname><given-names>L</given-names></name></person-group>. <article-title>Pathogenesis and immunobiology of brucellosis: review of <italic toggle="yes">Brucella</italic>-host interactions</article-title>. <source>Am J Pathol</source> (<year>2015</year>) <volume>185</volume>:<fpage>1505</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/j.ajpath.2015.03.003</pub-id><pub-id pub-id-type="pmid">25892682</pub-id><pub-id pub-id-type="pmcid">PMC4450313</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name><name name-style="western"><surname>Papadimitriou</surname><given-names>P</given-names></name><name name-style="western"><surname>Akritidis</surname><given-names>N</given-names></name><name name-style="western"><surname>Christou</surname><given-names>L</given-names></name><name name-style="western"><surname>Tsianos</surname><given-names>E</given-names></name></person-group>. <article-title>The new global map of human brucellosis</article-title>. <source>Lancet Infect Dis</source> (<year>2006</year>) <volume>6</volume>:<fpage>91</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/S1473-3099(06)70382-6</pub-id><pub-id pub-id-type="pmid">16439329</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carvalho</surname><given-names>N</given-names></name><name name-style="western"><surname>Mol</surname><given-names>J</given-names></name><name name-style="western"><surname>Xavier</surname><given-names>M</given-names></name><name name-style="western"><surname>Paixao</surname><given-names>T</given-names></name><name name-style="western"><surname>Lagew</surname><given-names>A</given-names></name><name name-style="western"><surname>Santos</surname><given-names>R</given-names></name></person-group><article-title>Pathogenesis of Bovine brucellosis</article-title>. <source>Vet J</source> (<year>2010</year>) <volume>184</volume>:<fpage>146</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/j.tvjl.2009.04.010</pub-id><pub-id pub-id-type="pmid">19733101</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brand&#227;o</surname><given-names>A</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>F</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>N</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>L</given-names></name><name name-style="western"><surname>Azevedo</surname><given-names>V</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>G</given-names></name><etal/></person-group><article-title>Host susceptibility to <italic toggle="yes">Brucella abortus</italic> infection is more pronounced in IFN-&#947; knockout than IL-12/&#946; 2-microglobulin double-deficient mice</article-title>. <source>Clin Dev Immunol</source> (<year>2012</year>) <volume>2012</volume>:<fpage>589494</fpage><pub-id pub-id-type="doi">10.1155/2012/589494</pub-id><pub-id pub-id-type="pmid">22194770</pub-id><pub-id pub-id-type="pmcid">PMC3238360</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name><name name-style="western"><surname>Akritidis</surname><given-names>N</given-names></name><name name-style="western"><surname>Bosilkovski</surname><given-names>M</given-names></name><name name-style="western"><surname>Tsianos</surname><given-names>E</given-names></name></person-group><article-title>Brucellosis</article-title>. <source>N Engl J Med</source> (<year>2005</year>) <volume>352</volume>:<fpage>2325</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMra050570</pub-id><pub-id pub-id-type="pmid">15930423</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haag</surname><given-names>A</given-names></name><name name-style="western"><surname>Myka</surname><given-names>K</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>MF</given-names></name><name name-style="western"><surname>Caro-Hern&#224;ndez</surname><given-names>P</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>G</given-names></name></person-group><article-title>Importance of lipopolysaccharide and cyclic &#946;-1,2-glucans in <italic toggle="yes">Brucella</italic>-mammalian infections</article-title>. <source>Int J Microbiol</source> (<year>2010</year>) <volume>2010</volume>:<fpage>124509</fpage><pub-id pub-id-type="doi">10.1155/2010/124509</pub-id><pub-id pub-id-type="pmid">21151694</pub-id><pub-id pub-id-type="pmcid">PMC2995898</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celli</surname><given-names>J</given-names></name><name name-style="western"><surname>de Chastellier</surname><given-names>C</given-names></name><name name-style="western"><surname>Franchini</surname><given-names>D</given-names></name><name name-style="western"><surname>Pizarro-Cerda</surname><given-names>J</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>J</given-names></name></person-group>. <article-title><italic toggle="yes">Brucella</italic> evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>198</volume>:<fpage>545</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20030088</pub-id><pub-id pub-id-type="pmid">12925673</pub-id><pub-id pub-id-type="pmcid">PMC2194179</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salcedo</surname><given-names>S</given-names></name><name name-style="western"><surname>Marchesini</surname><given-names>M</given-names></name><name name-style="western"><surname>Lalouard</surname><given-names>H</given-names></name><name name-style="western"><surname>Fuguier</surname><given-names>E</given-names></name><name name-style="western"><surname>Jolly</surname><given-names>G</given-names></name><name name-style="western"><surname>Balor</surname><given-names>S</given-names></name><etal/></person-group><article-title><italic toggle="yes">Brucella</italic> control of dendritic cell maturation is dependent on the TIR-containing protein Btp1</article-title>. <source>PLoS Pathog</source> (<year>2008</year>) <volume>4</volume>(<issue>2</issue>):<fpage>e21</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.0040021</pub-id><pub-id pub-id-type="pmid">18266466</pub-id><pub-id pub-id-type="pmcid">PMC2233671</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viadas</surname><given-names>C</given-names></name><name name-style="western"><surname>Rodr&#237;guez</surname><given-names>M</given-names></name><name name-style="western"><surname>Sangari</surname><given-names>F</given-names></name><name name-style="western"><surname>Gorvel</surname><given-names>J</given-names></name><name name-style="western"><surname>Garc&#237;a-Lobo</surname><given-names>J</given-names></name><name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>I</given-names></name></person-group>. <article-title>Transcriptome analysis of the <italic toggle="yes">Brucella abortus</italic> BvrR/BvrS two-component regulatory system</article-title>. <source>PLoS One</source> (<year>2010</year>) <volume>5</volume>:<fpage>e10216</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0010216</pub-id><pub-id pub-id-type="pmid">20422049</pub-id><pub-id pub-id-type="pmcid">PMC2858072</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ke</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ren</surname><given-names>H</given-names></name><etal/></person-group><article-title>Deletion of the small RNA chaperone protein Hfq down regulates genes related to virulence and confers protection against wild-type <italic toggle="yes">Brucella</italic> challenge in mice</article-title>. <source>Front Microbiol</source> (<year>2016</year>) <volume>20</volume>(<issue>6</issue>):<fpage>1570</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2015.01570</pub-id><pub-id pub-id-type="pmid">26834720</pub-id><pub-id pub-id-type="pmcid">PMC4718986</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beck</surname><given-names>B</given-names></name><name name-style="western"><surname>Tabatabai</surname><given-names>L</given-names></name><name name-style="western"><surname>Mayfield</surname><given-names>J</given-names></name></person-group>. <article-title>A protein isolated from <italic toggle="yes">Brucella abortus</italic> is a Cu-Zn superoxide dismutase</article-title>. <source>Biochemistry</source> (<year>1990</year>) <volume>29</volume>:<fpage>372</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1021/bi00454a010</pub-id><pub-id pub-id-type="pmid">2105741</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pratt</surname><given-names>A</given-names></name><name name-style="western"><surname>DiDonate</surname><given-names>M</given-names></name><name name-style="western"><surname>Shim</surname><given-names>D</given-names></name><name name-style="western"><surname>Cabelli</surname><given-names>D</given-names></name><name name-style="western"><surname>Bruns</surname><given-names>C</given-names></name><name name-style="western"><surname>Belzer</surname><given-names>C</given-names></name><etal/></person-group><article-title>Structural, functional, and immunogenic insights on Cu, Zn superoxide dismutase pathogenic virulence factors from <italic toggle="yes">Neisseria meningitidis</italic> and <italic toggle="yes">Brucella abortus</italic></article-title>. <source>J Bacteriol</source> (<year>2015</year>) <volume>197</volume>:<fpage>3834</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00343-15</pub-id><pub-id pub-id-type="pmid">26459556</pub-id><pub-id pub-id-type="pmcid">PMC4652047</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#241;ate</surname><given-names>A</given-names></name><name name-style="western"><surname>C&#233;spedes</surname><given-names>S</given-names></name><name name-style="western"><surname>Cabrera</surname><given-names>A</given-names></name><name name-style="western"><surname>Rivers</surname><given-names>R</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>A</given-names></name><name name-style="western"><surname>Munoz</surname><given-names>C</given-names></name><etal/></person-group><article-title>A DNA vaccine encoding Cu, Zn superoxide dismutase of <italic toggle="yes">Brucella abortus</italic> induces protective immunity in BALB/c mice</article-title>. <source>Infect Immun</source> (<year>2003</year>) <volume>71</volume>:<fpage>4857</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.71.9.4857-4861.2003</pub-id><pub-id pub-id-type="pmid">12933826</pub-id><pub-id pub-id-type="pmcid">PMC187304</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz-Montesino</surname><given-names>C</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>A</given-names></name><name name-style="western"><surname>Rivers</surname><given-names>R</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Folch</surname><given-names>H</given-names></name><name name-style="western"><surname>C&#233;spedes</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of <italic toggle="yes">Brucella abortus</italic> induces SOD-specific CD4+ and CD8+ T cells</article-title>. <source>Infect Immun</source> (<year>2004</year>) <volume>72</volume>:<fpage>2081</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.72.4.2081-2087.2004</pub-id><pub-id pub-id-type="pmid">15039330</pub-id><pub-id pub-id-type="pmcid">PMC375181</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#225;ndara</surname><given-names>B</given-names></name><name name-style="western"><surname>Merino</surname><given-names>A</given-names></name><name name-style="western"><surname>Rogel</surname><given-names>M</given-names></name><name name-style="western"><surname>Mart&#237;nez-Romero</surname><given-names>E</given-names></name></person-group>. <article-title>Limited genetic diversity of <italic toggle="yes">Brucella</italic> spp</article-title>. <source>J Clin Microbiol</source> (<year>2001</year>) <volume>39</volume>:<fpage>235</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1128/JCM.39.1.235-240.2001</pub-id><pub-id pub-id-type="pmid">11136777</pub-id><pub-id pub-id-type="pmcid">PMC87708</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajashekara</surname><given-names>G</given-names></name><name name-style="western"><surname>Glasner</surname><given-names>J</given-names></name><name name-style="western"><surname>Glover</surname><given-names>D</given-names></name><name name-style="western"><surname>Splitter</surname><given-names>G</given-names></name></person-group>. <article-title>Comparative whole-genome hybridization reveals genomic islands in <italic toggle="yes">Brucella</italic> species</article-title>. <source>J Bacteriol</source> (<year>2004</year>) <volume>186</volume>(<issue>15</issue>):<fpage>5040</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1128/JB.186.15.5040-5051.2004</pub-id><pub-id pub-id-type="pmid">15262941</pub-id><pub-id pub-id-type="pmcid">PMC451633</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ratushna</surname><given-names>V</given-names></name><name name-style="western"><surname>Sturgill</surname><given-names>D</given-names></name><name name-style="western"><surname>Ramamoorthy</surname><given-names>S</given-names></name><name name-style="western"><surname>Reichow</surname><given-names>S</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lathigra</surname><given-names>R</given-names></name><etal/></person-group><article-title>Molecular targets for rapid identification of <italic toggle="yes">Brucella</italic> spp</article-title>. <source>BMC Microbiol</source> (<year>2006</year>) <volume>22</volume>(<issue>6</issue>):<fpage>13</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2180-6-13</pub-id><pub-id pub-id-type="pmid">16504063</pub-id><pub-id pub-id-type="pmcid">PMC1413539</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortiz-Rom&#225;n</surname><given-names>L</given-names></name><name name-style="western"><surname>Riquelme-Neira</surname><given-names>R</given-names></name><name name-style="western"><surname>Vidal</surname><given-names>R</given-names></name><name name-style="western"><surname>O&#241;ate</surname><given-names>A</given-names></name></person-group>. <article-title>Roles of genomic island 3 (GI-3) BAB1_0267 and BAB1_0270 open reading frames (ORFs) in the virulence of <italic toggle="yes">Brucella abortus</italic> 2308</article-title>. <source>Vet Microbiol</source> (<year>2014</year>) <volume>172</volume>:<fpage>279</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetmic.2014.05.005</pub-id><pub-id pub-id-type="pmid">24928771</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>C&#233;spedes</surname><given-names>S</given-names></name><name name-style="western"><surname>Salgado</surname><given-names>P</given-names></name><name name-style="western"><surname>Retamal-D&#237;az</surname><given-names>A</given-names></name><name name-style="western"><surname>Vidal</surname><given-names>R</given-names></name><name name-style="western"><surname>O&#241;ate</surname><given-names>A</given-names></name></person-group><article-title>Roles of genomic island 3 (IG3) BAB1_0278 and BAB1_0263 open reading frames (ORFs) in the virulence of <italic toggle="yes">Brucella abortus</italic> in BALB/c mice</article-title>. <source>Vet Microbiol</source> (<year>2012</year>) <volume>156</volume>:<fpage>1</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetmic.2011.09.025</pub-id><pub-id pub-id-type="pmid">22005180</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#243;mez</surname><given-names>L</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>F</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>P</given-names></name><name name-style="western"><surname>Flores</surname><given-names>M</given-names></name><name name-style="western"><surname>Molina</surname><given-names>R</given-names></name><name name-style="western"><surname>Coloma</surname><given-names>R</given-names></name><etal/></person-group><article-title>Immunogenicity and protective response induced by recombinant plasmids based on the BAB1_0267 and BAB1_0270 open reading frames of <italic toggle="yes">Brucella abortus</italic> 2308 in BALB/c mice</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2016</year>) <volume>6</volume>:<fpage>117</fpage>.<pub-id pub-id-type="doi">10.3389/fcimb.2016.00117</pub-id><pub-id pub-id-type="pmid">27747197</pub-id><pub-id pub-id-type="pmcid">PMC5041321</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sislema-Egas</surname><given-names>F</given-names></name><name name-style="western"><surname>C&#233;spedes</surname><given-names>S</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>P</given-names></name><name name-style="western"><surname>Retamal-D&#237;az</surname><given-names>A</given-names></name><name name-style="western"><surname>S&#225;ez</surname><given-names>D</given-names></name><name name-style="western"><surname>O&#241;ate</surname><given-names>A</given-names></name></person-group>. <article-title>Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of <italic toggle="yes">Brucella abortus</italic> in BALB/c mice</article-title>. <source>Vaccine</source> (<year>2012</year>) <volume>30</volume>:<fpage>7286</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.09.039</pub-id><pub-id pub-id-type="pmid">23026687</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riquelme-Neira</surname><given-names>R</given-names></name><name name-style="western"><surname>Retamal-D&#237;az</surname><given-names>A</given-names></name><name name-style="western"><surname>Acu&#241;a</surname><given-names>F</given-names></name><name name-style="western"><surname>Riquelme</surname><given-names>P</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>A</given-names></name><name name-style="western"><surname>S&#225;ez</surname><given-names>D</given-names></name><etal/></person-group><article-title>Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of <italic toggle="yes">Brucella abortus</italic> in BALB/c mice</article-title>. <source>Vaccine</source> (<year>2013</year>) <volume>31</volume>:<fpage>3663</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2013.06.013</pub-id><pub-id pub-id-type="pmid">23834811</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fu</surname><given-names>S</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>X</given-names></name><etal/></person-group><article-title>Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against <italic toggle="yes">Brucella abortus</italic> 544 infection in BALB/c mice</article-title>. <source>Vet Microbiol</source> (<year>2012</year>) <volume>161</volume>:<fpage>137</fpage>&#8211;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetmic.2012.07.016</pub-id><pub-id pub-id-type="pmid">22854331</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorneles</surname><given-names>E</given-names></name><name name-style="western"><surname>Lima</surname><given-names>G</given-names></name><name name-style="western"><surname>Teixeira-Carvalho</surname><given-names>A</given-names></name><name name-style="western"><surname>Ara&#250;jo</surname><given-names>M</given-names></name><name name-style="western"><surname>Martins-Filho</surname><given-names>O</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Immune response of calves vaccinated with <italic toggle="yes">Brucella abortus</italic> S19 or RB51 and revaccinated with RB51</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>(<issue>9</issue>):<fpage>e0136696</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0136696</pub-id><pub-id pub-id-type="pmid">26352261</pub-id><pub-id pub-id-type="pmcid">PMC4564183</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schurig</surname><given-names>G</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Corbel</surname><given-names>M</given-names></name></person-group>. <article-title>Brucellosis vaccines: past, present and future</article-title>. <source>Vet Microbiol</source> (<year>2002</year>) <volume>90</volume>:<fpage>479</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/S0378-1135(02)00255-9</pub-id><pub-id pub-id-type="pmid">12414166</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ingolotti</surname><given-names>M</given-names></name><name name-style="western"><surname>Kawelekar</surname><given-names>O</given-names></name><name name-style="western"><surname>Shedlock</surname><given-names>D</given-names></name><name name-style="western"><surname>Muthumani</surname><given-names>K</given-names></name><name name-style="western"><surname>Weiner</surname><given-names>D</given-names></name></person-group><article-title>DNA vaccines for targeting bacterial infections</article-title>. <source>Expert Rev Vaccines</source> (<year>2010</year>) <volume>9</volume>:<fpage>747</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1586/erv.10.57</pub-id><pub-id pub-id-type="pmid">20624048</pub-id><pub-id pub-id-type="pmcid">PMC2962930</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T</given-names></name><name name-style="western"><surname>Du</surname><given-names>F</given-names></name><etal/></person-group><article-title>Immunogenicity of a multi-epitope DNA vaccine against hantavirus</article-title>. <source>Hum Vaccin Immuniother</source> (<year>2012</year>) <volume>8</volume>:<fpage>208</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.4161/hv.18389</pub-id><pub-id pub-id-type="pmid">22426376</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Yue</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name></person-group>. <article-title>DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope <italic toggle="yes">Mycobacterium tuberculosis</italic> vaccine</article-title>. <source>Microbiol Imunol</source> (<year>2016</year>) <volume>60</volume>:<fpage>634</fpage>&#8211;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1111/1348-0421.12410</pub-id><pub-id pub-id-type="pmid">27531823</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cui</surname><given-names>N</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Shen</surname><given-names>F</given-names></name><etal/></person-group><article-title>Evaluation of a chimeric multi-epitope-based DNA vaccine against subgroup J avian leukosis virus in chickens</article-title>. <source>Vaccine</source> (<year>2016</year>) <volume>34</volume>:<fpage>3751</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2016.06.004</pub-id><pub-id pub-id-type="pmid">27318415</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salimi</surname><given-names>N</given-names></name><name name-style="western"><surname>Fleri</surname><given-names>W</given-names></name><name name-style="western"><surname>Peters</surname><given-names>B</given-names></name><name name-style="western"><surname>Sette</surname><given-names>A</given-names></name></person-group>. <article-title>The immune epitope database: a historical retrospective of the first decade</article-title>. <source>Immunology</source> (<year>2012</year>) <volume>137</volume>:<fpage>117</fpage>&#8211;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2567.2012.03611.x</pub-id><pub-id pub-id-type="pmid">22681406</pub-id><pub-id pub-id-type="pmcid">PMC3461392</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>B</given-names></name><name name-style="western"><surname>Sette</surname><given-names>A</given-names></name></person-group>. <article-title>Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method</article-title>. <source>BMC Bioinformatics</source> (<year>2005</year>) <volume>6</volume>:<fpage>132</fpage>.<pub-id pub-id-type="doi">10.1186/1471-2105-6-132</pub-id><pub-id pub-id-type="pmid">15927070</pub-id><pub-id pub-id-type="pmcid">PMC1173087</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>M</given-names></name><name name-style="western"><surname>Lundegaard</surname><given-names>C</given-names></name><name name-style="western"><surname>Worning</surname><given-names>P</given-names></name><name name-style="western"><surname>Lauemoller</surname><given-names>S</given-names></name><name name-style="western"><surname>Lamberth</surname><given-names>K</given-names></name><name name-style="western"><surname>Buus</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reliable prediction of T-cell epitopes using neural networks with novel sequence representations</article-title>. <source>Protein Sci</source> (<year>2003</year>) <volume>12</volume>:<fpage>1007</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1110/ps.0239403</pub-id><pub-id pub-id-type="pmid">12717023</pub-id><pub-id pub-id-type="pmcid">PMC2323871</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sidney</surname><given-names>J</given-names></name><name name-style="western"><surname>Assarsson</surname><given-names>E</given-names></name><name name-style="western"><surname>Moore</surname><given-names>C</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>S</given-names></name><name name-style="western"><surname>Pinilla</surname><given-names>C</given-names></name><name name-style="western"><surname>Sette</surname><given-names>A</given-names></name><etal/></person-group><article-title>Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries</article-title>. <source>Immunome Res</source> (<year>2008</year>) <volume>4</volume>:<fpage>2</fpage>.<pub-id pub-id-type="doi">10.1186/1745-7580-4-2</pub-id><pub-id pub-id-type="pmid">18221540</pub-id><pub-id pub-id-type="pmcid">PMC2248166</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#241;ate</surname><given-names>A</given-names></name><name name-style="western"><surname>Andrew</surname><given-names>A</given-names></name><name name-style="western"><surname>Beltran</surname><given-names>A</given-names></name><name name-style="western"><surname>Eller</surname><given-names>G</given-names></name><name name-style="western"><surname>Schurig</surname><given-names>G</given-names></name><name name-style="western"><surname>Folch</surname><given-names>H</given-names></name></person-group>. <article-title>Frequent exposure of mice to crude <italic toggle="yes">Brucella abortus</italic> proteins down-regulates immune response</article-title>. <source>J Vet Med B Infect Dis Vet Public Health</source> (<year>2000</year>) <volume>47</volume>:<fpage>677</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1046/j.1439-0450.2000.00402.x</pub-id><pub-id pub-id-type="pmid">11244868</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>M</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>E</given-names></name><name name-style="western"><surname>Folch</surname><given-names>H</given-names></name><name name-style="western"><surname>S&#225;ez</surname><given-names>D</given-names></name><name name-style="western"><surname>Cabrera</surname><given-names>A</given-names></name><name name-style="western"><surname>Salgado</surname><given-names>P</given-names></name><etal/></person-group><article-title>Cloning, expression and immunogenicity of the translation initiation factor 3 homologue of <italic toggle="yes">Brucella abortus</italic></article-title>. <source>Immunobiol</source> (<year>2009</year>) <volume>214</volume>:<fpage>113</fpage>&#8211;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.imbio.2008.07.004</pub-id><pub-id pub-id-type="pmid">19167989</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabai</surname><given-names>L</given-names></name><name name-style="western"><surname>Pugh</surname><given-names>G</given-names></name></person-group>. <article-title>Modulation of immune responses in Balb/c mice vaccinated with <italic toggle="yes">Brucella abortus</italic> Cu-Zn superoxide dismutase synthetic peptide vaccine</article-title>. <source>Vaccine</source> (<year>1994</year>) <volume>12</volume>:<fpage>919</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/0264-410X(94)90035-3</pub-id><pub-id pub-id-type="pmid">7526568</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Livingston</surname><given-names>B</given-names></name><name name-style="western"><surname>Crimi</surname><given-names>C</given-names></name><name name-style="western"><surname>Newman</surname><given-names>M</given-names></name><name name-style="western"><surname>Higashimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Appella</surname><given-names>E</given-names></name><name name-style="western"><surname>Sidney</surname><given-names>J</given-names></name><etal/></person-group><article-title>A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>168</volume>:<fpage>5499</fpage>&#8211;<lpage>506</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.168.11.5499</pub-id><pub-id pub-id-type="pmid">12023344</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deqiu</surname><given-names>S</given-names></name><name name-style="western"><surname>Donglou</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiming</surname><given-names>Y</given-names></name></person-group><article-title>Epidemiology and control of brucellosis in China</article-title>. <source>Vet Microbiol</source> (<year>2002</year>) <volume>90</volume>:<fpage>165</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/S0378-1135(02)00252-3</pub-id><pub-id pub-id-type="pmid">12414142</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group><article-title>Reverse vaccinology</article-title>. <source>Curr Opin Microbiol</source> (<year>2000</year>) <volume>3</volume>:<fpage>445</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/S1369-5274(00)00119-3</pub-id><pub-id pub-id-type="pmid">11050440</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barouch</surname><given-names>D</given-names></name><name name-style="western"><surname>Alter</surname><given-names>G</given-names></name><name name-style="western"><surname>Broge</surname><given-names>T</given-names></name><name name-style="western"><surname>Linde</surname><given-names>C</given-names></name><name name-style="western"><surname>Ackerman</surname><given-names>M</given-names></name><name name-style="western"><surname>Brown</surname><given-names>E</given-names></name><etal/></person-group><article-title>Protective eficacy of adenovirus/protein vaccines a gainst SIV challenges in rhesus monkeys</article-title>. <source>Science</source> (<year>2015</year>) <volume>349</volume>:<fpage>320</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1126/science.aab3886</pub-id><pub-id pub-id-type="pmid">26138104</pub-id><pub-id pub-id-type="pmcid">PMC4653134</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da&#8217;Dara</surname><given-names>A</given-names></name><name name-style="western"><surname>Skelly</surname><given-names>P</given-names></name><name name-style="western"><surname>Walker</surname><given-names>C</given-names></name><name name-style="western"><surname>Harn</surname><given-names>D</given-names></name></person-group>. <article-title>A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following <italic toggle="yes">Schistosoma mansoni</italic> infection</article-title>. <source>Parasite Immunol</source> (<year>2003</year>) <volume>25</volume>:<fpage>429</fpage>&#8211;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-3024.2003.00651.x</pub-id><pub-id pub-id-type="pmid">14651590</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gurunathan</surname><given-names>S</given-names></name><name name-style="western"><surname>Klinman</surname><given-names>D</given-names></name><name name-style="western"><surname>Seder</surname><given-names>R</given-names></name></person-group><article-title>DNA vaccines: immunology, application, and optimization</article-title>. <source>Ann Rev Immunol</source> (<year>2000</year>) <volume>18</volume>:<fpage>927</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.18.1.927</pub-id><pub-id pub-id-type="pmid">10837079</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gurunathan</surname><given-names>S</given-names></name><name name-style="western"><surname>Stobie</surname><given-names>L</given-names></name><name name-style="western"><surname>Prussin</surname><given-names>C</given-names></name><name name-style="western"><surname>Sacks</surname><given-names>D</given-names></name><name name-style="western"><surname>Glaichenhaus</surname><given-names>N</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>A</given-names></name><etal/></person-group><article-title>Requirements for the maintenance of Th1 immunity <italic toggle="yes">in vivo</italic> following DNA vaccination: a potential immunoregulatory role for CD8+ T cells</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>165</volume>:<fpage>915</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.165.2.915</pub-id><pub-id pub-id-type="pmid">10878366</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>S</given-names></name><name name-style="western"><surname>Xue</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name></person-group>. <article-title>Protective effect of a multiantigenic DNA vaccine against <italic toggle="yes">Toxoplasma gondii</italic> with co-delivery of IL-12 in mice</article-title>. <source>Parasite Immunol</source> (<year>2008</year>) <volume>30</volume>:<fpage>309</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-3024.2008.01025.x</pub-id><pub-id pub-id-type="pmid">18331395</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>D</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W</given-names></name><name name-style="western"><surname>Du</surname><given-names>A</given-names></name></person-group>. <article-title>Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated <italic toggle="yes">Salmonella typhimurium</italic> against <italic toggle="yes">Toxoplasma gondii</italic> infection in mice</article-title>. <source>Vet Parasitol</source> (<year>2009</year>) <volume>166</volume>:<fpage>220</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetpar.2009.08.016</pub-id><pub-id pub-id-type="pmid">19740610</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>D</given-names></name><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cai</surname><given-names>H</given-names></name></person-group>. <article-title>A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against <italic toggle="yes">Brucella abortus</italic> 2308 by inducing specific CTL responses</article-title>. <source>DNA Cell Biol</source> (<year>2007</year>) <volume>26</volume>:<fpage>435</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1089/dna.2006.0552</pub-id><pub-id pub-id-type="pmid">17570767</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sette</surname><given-names>A</given-names></name><name name-style="western"><surname>Fikes</surname><given-names>J</given-names></name></person-group>. <article-title>Epitope-based vaccines: an update on epitope identification, vaccine design and delivery</article-title>. <source>Curr Opin Immunol</source> (<year>2003</year>) <volume>15</volume>:<fpage>461</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1016/S0952-7915(03)00083-9</pub-id><pub-id pub-id-type="pmid">12900280</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Depla</surname><given-names>E</given-names></name><name name-style="western"><surname>Van der Aa</surname><given-names>A</given-names></name><name name-style="western"><surname>Livingston</surname><given-names>B</given-names></name><name name-style="western"><surname>Crimi</surname><given-names>C</given-names></name><name name-style="western"><surname>Allosery</surname><given-names>K</given-names></name><name name-style="western"><surname>De Brabandere</surname><given-names>V</given-names></name><etal/></person-group><article-title>Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections</article-title>. <source>J Virol</source> (<year>2008</year>) <volume>82</volume>:<fpage>435</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01505-07</pub-id><pub-id pub-id-type="pmid">17942551</pub-id><pub-id pub-id-type="pmcid">PMC2224390</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Kang</surname><given-names>R</given-names></name></person-group>. <article-title>The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2008</year>) <volume>377</volume>:<fpage>221</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbrc.2008.09.125</pub-id><pub-id pub-id-type="pmid">18840402</pub-id><pub-id pub-id-type="pmcid">PMC7117539</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moss</surname><given-names>S</given-names></name><name name-style="western"><surname>Moise</surname><given-names>L</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D</given-names></name><name name-style="western"><surname>Kim</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group><article-title>HelicoVax: epitope-based therapeutic <italic toggle="yes">Helicobacter pylori</italic> vaccination in a mouse model</article-title>. <source>Vaccine</source> (<year>2011</year>) <volume>29</volume>:<fpage>2085</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2010.12.130</pub-id><pub-id pub-id-type="pmid">21236233</pub-id><pub-id pub-id-type="pmcid">PMC3046230</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nezafat</surname><given-names>N</given-names></name><name name-style="western"><surname>Ghasemi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Javadi</surname><given-names>G</given-names></name><name name-style="western"><surname>Khoshnoud</surname><given-names>M</given-names></name><name name-style="western"><surname>Omidinia</surname><given-names>E</given-names></name></person-group>. <article-title>A novel multi-epitope peptide vaccine against cancer: an <italic toggle="yes">in silico</italic> approach</article-title>. <source>J Theor Biol</source> (<year>2014</year>) <volume>349</volume>:<fpage>121</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.jtbi.2014.01.018</pub-id><pub-id pub-id-type="pmid">24512916</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmoodi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nezafat</surname><given-names>N</given-names></name><name name-style="western"><surname>Barzegar</surname><given-names>A</given-names></name><name name-style="western"><surname>Negahdaripour</surname><given-names>M</given-names></name><name name-style="western"><surname>Nikanfar</surname><given-names>A</given-names></name><name name-style="western"><surname>Zarghami</surname><given-names>N</given-names></name><etal/></person-group><article-title>Harnessing bioinformatics for designing a novel multi-epitope peptide vaccine against breast cancer</article-title>. <source>Curr Pharm Biotechnol</source> (<year>2016</year>) <volume>17</volume>:<fpage>1110</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.2174/1389201017666160914191106</pub-id><pub-id pub-id-type="pmid">27633889</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>A</given-names></name><name name-style="western"><surname>Peng</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>J</given-names></name><name name-style="western"><surname>Gao</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Chemical gene synthesis: strategies, softwares, error corrections, and applications</article-title>. <source>FEMS Microbiol Rev</source> (<year>2008</year>) <volume>32</volume>:<fpage>522</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6976.2008.00109.x</pub-id><pub-id pub-id-type="pmid">18393987</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Schuler</surname><given-names>MM</given-names></name><name name-style="western"><surname>Nastke</surname><given-names>M-D</given-names></name><name name-style="western"><surname>Stevanovi&#263;</surname><given-names>S</given-names></name></person-group><article-title>SYFPEITHI, database for searching and T-cell epitope prediction</article-title>. In: <person-group person-group-type="editor"><name name-style="western"><surname>Flower</surname><given-names>DR</given-names></name></person-group>, editor. <source>Immunoinformatics. Predicting Immunogenicity in silico</source>. <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name> (<year>2007</year>). p. <fpage>75</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-60327-118-9_5</pub-id><pub-id pub-id-type="pmid">18449993</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vita</surname><given-names>R</given-names></name><name name-style="western"><surname>Overton</surname><given-names>J</given-names></name><name name-style="western"><surname>Greenbaum</surname><given-names>J</given-names></name><name name-style="western"><surname>Ponomarenko</surname><given-names>J</given-names></name><name name-style="western"><surname>Clark</surname><given-names>J</given-names></name><name name-style="western"><surname>Cantrell</surname><given-names>J</given-names></name><etal/></person-group><article-title>The immune epitope database (IEDB) 3.0</article-title>. <source>Nucleic Acids Res</source> (<year>2015</year>) <volume>43</volume>:<fpage>D405</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1093/nar/gku938</pub-id><pub-id pub-id-type="pmid">25300482</pub-id><pub-id pub-id-type="pmcid">PMC4384014</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golding</surname><given-names>B</given-names></name><name name-style="western"><surname>Scott</surname><given-names>D</given-names></name><name name-style="western"><surname>Scharf</surname><given-names>O</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zaitseva</surname><given-names>M</given-names></name><name name-style="western"><surname>Lapham</surname><given-names>C</given-names></name><etal/></person-group><article-title>Immunity and protection against <italic toggle="yes">Brucella abortus</italic></article-title>. <source>Microbes Infect</source> (<year>2001</year>) <volume>3</volume>:<fpage>43</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/S1286-4579(00)01350-2</pub-id><pub-id pub-id-type="pmid">11226853</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>